FitLife Brands, Inc. (FTLF) stock
FTLFNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/301% below fair value
$6.89+0.06 (+0.88%)
Close on Nov 18, 2026Market cap $64.70MP/E 36.3Yield –
FitLife Brands free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
FitLife Brands's free cash flow for the twelve months ending Jun 30, 2026 was $10.02M. For fiscal 2025 it was $7.40M, down 22.9% from the year before. The highest annual figure on record is $9.60M in fiscal 2024.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.40M | -22.9% |
| FY2024 | Dec 31, 2024 | $9.60M | +133.3% |
| FY2023 | Dec 31, 2023 | $4.11M | -0.4% |
| FY2022 | Dec 31, 2022 | $4.13M | +1500.8% |
| FY2018 | Dec 31, 2018 | $258.00K | -46.4% |
| FY2017 | Dec 31, 2017 | $481.00K | +1842.3% |
| FY2016 | Dec 31, 2016 | $24.76K | – |
| FY2015 | Dec 31, 2015 | -$2.47M | -264.2% |
| FY2014 | Dec 31, 2014 | $1.50M | +1305.9% |
| FY2011 | Dec 31, 2011 | $106.91K | – |
| FY2010 | Dec 31, 2010 | -$1.87M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $3.64M | +279.8% |
| Q1 FY2026 | Mar 31, 2026 | $2.48M | +21.3% |
| Q4 FY2025 | Dec 31, 2025 | $239.00K | -84.8% |
| Q3 FY2025 | Sep 30, 2025 | $3.66M | -27.1% |
| Q4 FY2024 | Dec 31, 2024 | $957.00K | -31.7% |
| Q3 FY2024 | Sep 30, 2024 | $2.05M | +110.6% |
| Q2 FY2024 | Jun 30, 2024 | $1.57M | +4.1% |
| Q1 FY2024 | Mar 31, 2024 | $5.03M | +2066.4% |
| Q4 FY2023 | Dec 31, 2023 | $1.40M | – |
| Q3 FY2023 | Sep 30, 2023 | $972.00K | -63.0% |
| Q2 FY2023 | Jun 30, 2023 | $1.51M | +161.8% |
| Q1 FY2023 | Mar 31, 2023 | $232.00K | -8.3% |
| Q4 FY2022 | Dec 31, 2022 | -$873.00K | – |
| Q3 FY2022 | Sep 30, 2022 | $2.63M | +501.3% |
| Q4 FY2018 | Dec 31, 2018 | $576.00K | – |
| Q4 FY2017 | Dec 31, 2017 | $253.00K | – |
| Q3 FY2017 | Sep 30, 2017 | -$186.00K | -202.7% |
| Q2 FY2017 | Jun 30, 2017 | $436.57K | -68.1% |
| Q1 FY2017 | Mar 31, 2017 | -$22.57K | – |
| Q4 FY2016 | Dec 31, 2016 | -$311.28K | – |
| Q3 FY2016 | Sep 30, 2016 | $181.06K | – |
| Q2 FY2016 | Jun 30, 2016 | $1.37M | – |
See a number that looks wrong?